Abstract Aims The European Society of Cardiology (ESC) has released three consecutive
guidelines within 5 years addressing cardiovascular prevention, risk scores, and cholesterol …

Objective To determine the detection rate (sensitivity) of the high-risk strategy recommended
in the European Society of Cardiology (ESC) and National Institute for Health and Care …

Objective To determine if the changes in the European Society Cardiology/European
Atherosclerotic Society (ESC/EAS) guidelines improved the identification for primary …

Recently, primary prevention with statins was liberalized in the USA and UK but restricted in
many comparable European countries. Supported by risk-benefit and cost-effectiveness …

Previous studies assessing healthcare provider compliance to the 2013 American College
of Cardiology/American Heart Association (ACC/AHA) cholesterol guidelines indicate a …

Background Current risk scores to estimate atherosclerotic cardiovascular disease (ASCVD)
risk and allocate statins in at-risk persons have largely been developed in Western …

Importance For primary prevention of atherosclerotic cardiovascular disease (ASCVD), the
2021 European Society of Cardiology (ESC) guidelines on statin use (hereafter European …

Abstract Aims The 2019 vs. 2016 European Society of Cardiology/European Atherosclerosis
Society (ESC/EAS) dyslipidaemia guidelines contains new recommendations for primary …

Purpose Many adults with atherosclerotic cardiovascular disease (ASCVD) who are
recommended to take a statin, ezetimibe and/or a proprotein convertase subtilisin/kexin type …

Lipid-lowering therapy is a key cornerstone in secondary prevention in patients with
coronary artery disease. 1 Current guidelines suggest a low-density lipoprotein (LDL) …